S&P 500   3,351.60 (+1.61%)
DOW   27,584.06 (+1.51%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
S&P 500   3,351.60 (+1.61%)
DOW   27,584.06 (+1.51%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
S&P 500   3,351.60 (+1.61%)
DOW   27,584.06 (+1.51%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
S&P 500   3,351.60 (+1.61%)
DOW   27,584.06 (+1.51%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
Log in
LON:SN

Smith & Nephew Share Forecast, Price & News

GBX 1,452
-8.00 (-0.55 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
1,434
Now: GBX 1,452
1,455.50
50-Day Range
1,450
MA: GBX 1,537.61
1,611.50
52-Week Range
1,055.01
Now: GBX 1,452
2,023
Volume1.63 million shs
Average Volume343,671 shs
Market Capitalization£12.71 billion
P/E Ratio32.56
Dividend Yield2.04%
BetaN/A
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder. It also provides arthroscopic enabling technologies for healthcare providers comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue. In addition, the company offers trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; knee implant products for specialized knee replacement procedures; and hip implant products for the reconstruction of hip joints. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration; and advanced wound devices, such as traditional and single-use negative pressure wound therapy and hydrosurgery systems. Additionally, it offers meniscal repair system. It primarily serves the providers of medical and surgical treatments and services. Smith & Nephew plc was founded in 1856 and is headquartered in London, the United Kingdom.
Read More
Smith & Nephew logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.1Community Rank: 2.2Dividend Strength: 1.7Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.99 out of 5 stars


Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-74017646

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£4.69 billion
Cash FlowGBX 39.68 per share
Book ValueGBX 570.40 per share

Profitability

Miscellaneous

Employees16,377
Market Cap£12.71 billion
Next Earnings DateN/A
OptionableOptionable
GBX 1,452
-8.00 (-0.55 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SN News and Ratings via Email

Sign-up to receive the latest news and ratings for SN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Smith & Nephew (LON:SN) Frequently Asked Questions

How has Smith & Nephew's stock been impacted by Coronavirus?

Smith & Nephew's stock was trading at GBX 1,506 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SN stock has decreased by 3.6% and is now trading at GBX 1,452.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Smith & Nephew?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Smith & Nephew
.

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew declared a dividend on Wednesday, July 29th. Investors of record on Thursday, October 1st will be given a dividend of GBX 0.14 per share on Wednesday, October 28th. This represents a yield of 0.68%. The ex-dividend date is Thursday, October 1st. The official announcement can be accessed at this link.
View Smith & Nephew's dividend history
.

What price target have analysts set for SN?

10 Wall Street analysts have issued twelve-month target prices for Smith & Nephew's shares. Their forecasts range from GBX 1,553 to GBX 2,090. On average, they anticipate Smith & Nephew's stock price to reach GBX 1,782.25 in the next year. This suggests a possible upside of 22.7% from the stock's current price.
View analysts' price targets for Smith & Nephew
.

Who are some of Smith & Nephew's key competitors?

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Imperial Brands (IMB), Smith & Nephew (SNN), Alexion Pharmaceuticals (ALXN), Barclays (BARC), British American Tobacco Plc Ads (BATS), BHP Group (BHP), GlaxoSmithKline (GSK), Anglo American (AAL), Experian (EXPN) and Glencore (GLEN).

Who are Smith & Nephew's key executives?

Smith & Nephew's management team includes the following people:
  • Mr. Namal Nawana, CEO & Exec. Director (Age 48)
  • Mr. Graham Timothy Baker, CFO & Exec. Director (Age 51)
  • Mr. Mark Gladwell, Pres of Global Operations (Age 44)
  • Ms. Catheryn O'Rourke, Chief Legal & Compliance Officer (Age 46)
  • Mr. Joe Metzger, Sr. VP of Marketing Services & Communications

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the London Stock Exchange (LON) under the ticker symbol "SN."

How do I buy shares of Smith & Nephew?

Shares of SN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Smith & Nephew's stock price today?

One share of SN stock can currently be purchased for approximately GBX 1,452.

How big of a company is Smith & Nephew?

Smith & Nephew has a market capitalization of £12.71 billion and generates £4.69 billion in revenue each year. Smith & Nephew employs 16,377 workers across the globe.

What is Smith & Nephew's official website?

The official website for Smith & Nephew is www.smith-nephew.com.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is 15 Adam Street, LONDON, WC2N 6LA, United Kingdom. The company can be reached via phone at +44-20-74017646.

This page was last updated on 9/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.